Filter By
Filter By
Brand
Brand
Categories

Category: Home

Reference: SM99-1
€0.00 (tax incl.)
SU5402 is used in an embryonic stem cells (ESC) culture method with three inhibitors (3i: SU5402 for FGFR, PD184352 for ERK, and CHIR99021 for GSK3). It has been showed that this 3i method is extremely instrumental in...
Reference: SM99-5
€0.00 (tax incl.)
SU5402 is used in an embryonic stem cells (ESC) culture method with three inhibitors (3i: SU5402 for FGFR, PD184352 for ERK, and CHIR99021 for GSK3). It has been showed that this 3i method is extremely instrumental in...
Reference: SM99-10
€0.00 (tax incl.)
SU5402 is used in an embryonic stem cells (ESC) culture method with three inhibitors (3i: SU5402 for FGFR, PD184352 for ERK, and CHIR99021 for GSK3). It has been showed that this 3i method is extremely instrumental in...
Reference: SM99-50
€0.00 (tax incl.)
SU5402 is used in an embryonic stem cells (ESC) culture method with three inhibitors (3i: SU5402 for FGFR, PD184352 for ERK, and CHIR99021 for GSK3). It has been showed that this 3i method is extremely instrumental in...
Reference: SM100-2
€0.00 (tax incl.)
SU6668 inhibits proliferation of HUVEC and NIH3T3 cells in-vitro and induces >75% growth inhibition against a broad range of tumor types. SU6668 shows antiangiogenic, anti-inflammatory, antimetastatic and proapototic...
Reference: SM100-10
€0.00 (tax incl.)
SU6668 inhibits proliferation of HUVEC and NIH3T3 cells in-vitro and induces >75% growth inhibition against a broad range of tumor types. SU6668 shows antiangiogenic, anti-inflammatory, antimetastatic and proapototic...
Reference: SM100-50
€0.00 (tax incl.)
SU6668 inhibits proliferation of HUVEC and NIH3T3 cells in-vitro and induces >75% growth inhibition against a broad range of tumor types. SU6668 shows antiangiogenic, anti-inflammatory, antimetastatic and proapototic...
Reference: SM100-200
€0.00 (tax incl.)
SU6668 inhibits proliferation of HUVEC and NIH3T3 cells in-vitro and induces >75% growth inhibition against a broad range of tumor types. SU6668 shows antiangiogenic, anti-inflammatory, antimetastatic and proapototic...
Reference: SM101-10
€0.00 (tax incl.)
Sunitinib has been shown to impinge on the osteoblast differentiation process in-vitro. It exhibits antiangiogenic and antitumor activity in multiple xenograft models.
Reference: SM101-50
€0.00 (tax incl.)
Sunitinib has been shown to impinge on the osteoblast differentiation process in-vitro. It exhibits antiangiogenic and antitumor activity in multiple xenograft models.
Reference: SM101-300
€0.00 (tax incl.)
Sunitinib has been shown to impinge on the osteoblast differentiation process in-vitro. It exhibits antiangiogenic and antitumor activity in multiple xenograft models.
Reference: SM101-500
€0.00 (tax incl.)
Sunitinib has been shown to impinge on the osteoblast differentiation process in-vitro. It exhibits antiangiogenic and antitumor activity in multiple xenograft models.
Reference: SM101-1000
€0.00 (tax incl.)
Sunitinib has been shown to impinge on the osteoblast differentiation process in-vitro. It exhibits antiangiogenic and antitumor activity in multiple xenograft models.
Reference: SM102-10
€0.00 (tax incl.)
Tandutinib inhibits cellular proliferation and induces apoptosis. Tandutinib works as a stem-like cells targeted agent to increase efficiency of anticancer drugs and it has antineoplastic activity.
Reference: SM102-50
€0.00 (tax incl.)
Tandutinib inhibits cellular proliferation and induces apoptosis. Tandutinib works as a stem-like cells targeted agent to increase efficiency of anticancer drugs and it has antineoplastic activity.
Reference: SM102-100
€0.00 (tax incl.)
Tandutinib inhibits cellular proliferation and induces apoptosis. Tandutinib works as a stem-like cells targeted agent to increase efficiency of anticancer drugs and it has antineoplastic activity.
Reference: SM103-1
€0.00 (tax incl.)
TG101348 exhibits promising pharmacokinetic profiles. TG101348 inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less inhibitory effect on the self-renewal of CD34+ hematopoietic progenitors.
Reference: SM103-5
€0.00 (tax incl.)
TG101348 exhibits promising pharmacokinetic profiles. TG101348 inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less inhibitory effect on the self-renewal of CD34+ hematopoietic progenitors.
Reference: SM103-10
€0.00 (tax incl.)
TG101348 exhibits promising pharmacokinetic profiles. TG101348 inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less inhibitory effect on the self-renewal of CD34+ hematopoietic progenitors.
Reference: SM103-50
€0.00 (tax incl.)
TG101348 exhibits promising pharmacokinetic profiles. TG101348 inhibits erythropoiesis from induced pluripotent stem cells (iPSC), but has less inhibitory effect on the self-renewal of CD34+ hematopoietic progenitors.
Reference: SM35-2
€0.00 (tax incl.)
Thiazovivin protects human embryonic stem cells (hESC) in the absence of ECM by regulating E-cadherin mediated cell-cell interaction. Thiazovivin also promotes single cell passage of human pluripotent cells.
Reference: SM35-10
€0.00 (tax incl.)
Thiazovivin protects human embryonic stem cells (hESC) in the absence of ECM by regulating E-cadherin mediated cell-cell interaction. Thiazovivin also promotes single cell passage of human pluripotent cells.
Reference: SM35-50
€0.00 (tax incl.)
Thiazovivin protects human embryonic stem cells (hESC) in the absence of ECM by regulating E-cadherin mediated cell-cell interaction. Thiazovivin also promotes single cell passage of human pluripotent cells.
Reference: SM36-1
€0.00 (tax incl.)
HDAC is overexpressed in a variety of cancers and is closely correlated with oncogenic factors.
Reference: SM36-5
€0.00 (tax incl.)
HDAC is overexpressed in a variety of cancers and is closely correlated with oncogenic factors.
Reference: SM36-25
€0.00 (tax incl.)
HDAC is overexpressed in a variety of cancers and is closely correlated with oncogenic factors.
Reference: SM105-2
€0.00 (tax incl.)
TWS119 induces neuronal differentiation in pluripotent murine embryonal carcinoma cells and embryonic stem cells (ESC). Because neuronal differentiation can be achieved without embryoid bodies (EB) formation and RA...
Reference: SM105-10
€0.00 (tax incl.)
TWS119 induces neuronal differentiation in pluripotent murine embryonal carcinoma cells and embryonic stem cells (ESC). Because neuronal differentiation can be achieved without embryoid bodies (EB) formation and RA...
Reference: SM105-25
€0.00 (tax incl.)
TWS119 induces neuronal differentiation in pluripotent murine embryonal carcinoma cells and embryonic stem cells (ESC). Because neuronal differentiation can be achieved without embryoid bodies (EB) formation and RA...
Reference: SM105-50
€0.00 (tax incl.)
TWS119 induces neuronal differentiation in pluripotent murine embryonal carcinoma cells and embryonic stem cells (ESC). Because neuronal differentiation can be achieved without embryoid bodies (EB) formation and RA...
Reference: SM106-5
€0.00 (tax incl.)
Inhibition of MEK/ERK activity by specific MEK inhibitors PD98059 and U0126 rapidly causes the loss of human embryonic stem cells (hESC) pluripotency, acting as a promoter of hESC differentiation. U0126 is also useful...
Reference: SM106-25
€0.00 (tax incl.)
Inhibition of MEK/ERK activity by specific MEK inhibitors PD98059 and U0126 rapidly causes the loss of human embryonic stem cells (hESC) pluripotency, acting as a promoter of hESC differentiation. U0126 is also useful...
Reference: SM106-100
€0.00 (tax incl.)
Inhibition of MEK/ERK activity by specific MEK inhibitors PD98059 and U0126 rapidly causes the loss of human embryonic stem cells (hESC) pluripotency, acting as a promoter of hESC differentiation. U0126 is also useful...
Reference: SM106-300
€0.00 (tax incl.)
Inhibition of MEK/ERK activity by specific MEK inhibitors PD98059 and U0126 rapidly causes the loss of human embryonic stem cells (hESC) pluripotency, acting as a promoter of hESC differentiation. U0126 is also useful...
Reference: SM107-2
€0.00 (tax incl.)
Vandetanib has been shown to influence in the osteoblast differentiation process in-vitro.
Reference: SM107-25
€0.00 (tax incl.)
Vandetanib has been shown to influence in the osteoblast differentiation process in-vitro.
Reference: SM107-100
€0.00 (tax incl.)
Vandetanib has been shown to influence in the osteoblast differentiation process in-vitro.
Reference: SM107-500
€0.00 (tax incl.)
Vandetanib has been shown to influence in the osteoblast differentiation process in-vitro.
Reference: SM16-1
€0.00 (tax incl.)
WH-4-023 in combination with other small molecules supports the self-renewal of naive human embryonic stem cells and maintenance of ground state pluripotency.
Reference: SM16-5
€0.00 (tax incl.)
WH-4-023 in combination with other small molecules supports the self-renewal of naive human embryonic stem cells and maintenance of ground state pluripotency.
Reference: SM16-25
€0.00 (tax incl.)
WH-4-023 in combination with other small molecules supports the self-renewal of naive human embryonic stem cells and maintenance of ground state pluripotency.
Reference: SM16-50
€0.00 (tax incl.)
WH-4-023 in combination with other small molecules supports the self-renewal of naive human embryonic stem cells and maintenance of ground state pluripotency.
Reference: SM16-100
€0.00 (tax incl.)
WH-4-023 in combination with other small molecules supports the self-renewal of naive human embryonic stem cells and maintenance of ground state pluripotency.
Reference: SM16-500
€0.00 (tax incl.)
WH-4-023 in combination with other small molecules supports the self-renewal of naive human embryonic stem cells and maintenance of ground state pluripotency.
Reference: SM38-2
€0.00 (tax incl.)
XAV939 inhibits growth of DLD-1 cells, an APC-deficient colorectal cancer cell line.
Reference: SM38-10
€0.00 (tax incl.)
XAV939 inhibits growth of DLD-1 cells, an APC-deficient colorectal cancer cell line.
Reference: SM38-50
€0.00 (tax incl.)
XAV939 inhibits growth of DLD-1 cells, an APC-deficient colorectal cancer cell line.
Reference: SM38-200
€0.00 (tax incl.)
XAV939 inhibits growth of DLD-1 cells, an APC-deficient colorectal cancer cell line.
Reference: SM02-1
€0.00 (tax incl.)
Y-27632 increases the cloning efficiency of human embryonic stem cells (hESC). Enables the long term expansion of embryonic stem cells (ESC) with single cell passage. hESC treated with Y-27632 in a serum-free medium...
Reference: SM02-5
€0.00 (tax incl.)
Y-27632 increases the cloning efficiency of human embryonic stem cells (hESC). Enables the long term expansion of embryonic stem cells (ESC) with single cell passage. hESC treated with Y-27632 in a serum-free medium...
Reference: SM02-10
€0.00 (tax incl.)
Y-27632 increases the cloning efficiency of human embryonic stem cells (hESC). Enables the long term expansion of embryonic stem cells (ESC) with single cell passage. hESC treated with Y-27632 in a serum-free medium...
Reference: SM02-100
€0.00 (tax incl.)
Y-27632 increases the cloning efficiency of human embryonic stem cells (hESC). Enables the long term expansion of embryonic stem cells (ESC) with single cell passage. hESC treated with Y-27632 in a serum-free medium...

Menu

Settings